Last reviewed · How we verify
NCT04720170
Exploratory Study of the Efficacy of Standard of Care Revascularization of the Lower Extremity
NA trial testing Revascularization in Diabetic Peripheral Neuropathy in 30 participants. Status unknown.
15 July 2021
Quick facts
| Lead sponsor | Diabetes and Glandular Disease Clinic |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 February 2021 |
| Primary completion | 15 July 2021 |
| Estimated completion | 15 September 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Revascularization
Conditions studied
- Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →
Sponsor
Diabetes and Glandular Disease Clinic
Who can join
Adults 30 to 80, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of the standard of care revascularization of the lower extremity with the addition of revascularization of the lateral plantar artery and anterior pedal loop of the foot as treatment for diabetic peripheral neuropathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04720170
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Revascularization
Trials testing the same drug.
- NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting
- NCT06279663 — Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coro · NA · recruiting
- NCT05644158 — Mitochondrial Function in Peripheral Arterial Disease · NA · unknown
- NCT05570019 — Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD) · unknown
- NCT04252950 — Community-based Exercise Following Revascularization for PAD · NA · recruiting
Other recruiting trials for Diabetic Peripheral Neuropathy
Currently open trials in the same condition.
- NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
- NCT06591780 — Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy · NA · recruiting
- NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
- NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
- NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting
Other Diabetes and Glandular Disease Clinic trials
Trials by the same sponsor.
- NCT04125082 — A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injec · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04720170 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Diabetes and Glandular Disease Clinic
- Last refreshed: 22 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04720170.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing